Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins (Q36181172)

12 August 2017

title

Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins (English)

1 reference

12 August 2017

1 reference

Sood RK

1

1 reference

12 August 2017

Fattom A

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

Expert Opinion on Investigational Drugs

12 August 2017

published in

1 reference

12 August 2017

volume

7

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

333-347

1 reference

THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Polysialic acid units are spatially and temporally expressed in developing postnatal rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Studies on infection and immunity in experimental typhoid fever. III. Effect of prophylactic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Protective activity of Vi capsular polysaccharide vaccine against typhoid fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Polysaccharide-protein conjugates: a new generation of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine Is Immunogenic in Infants and Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Interaction of meningococcal group B monoclonal antibody and its Fab fragment with alpha 2-8-linked sialic acid polymers: requirement of a long oligosaccharide segment for binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Bacteremia at Boston City Hospital: Occurrence and Mortality during 12 Selected Years (1935-1972), with Special Reference to Hospital-Acquired Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Directed immune globulin for the prevention or treatment of neonatal group B streptococcal infections: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Serum therapy revisited: animal models of infection and development of passive antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Synthesis of a tetrasaccharide unit of the capsular polysaccharide of Streptococcus pneumoniae type 9V

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Synthesis of a spacer-containing repeating unit of the capsular polysaccharide of Streptococcus pneumoniae type 23F

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

Emergence of Antibiotic Resistance In Hospitals, 1935-1975

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.3.333

21 January 2018

Identifiers

DOI

10.1517/13543784.7.3.333

1 reference

12 August 2017

1 reference